IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
NEW YORK, NY AND CAMBRIDGE,
Aurum scientist appointed to new journal editorial board
Aurum Scientist Lucy Chimoyi has been appointed to the editorial board of the new PLOS Global Public Health Journal which is aimed at charting a new path towards equity, diversity,
Prof Pontiano Kaleebu joins Aurum Board
Aurum is pleased to announce the appointment of renowned researcher Professor Pontiano Kaleebu to its Board of Directors.
Prof Kaleebu is a Sub-Saharan African Network for TB/HIV Research Excellence
Aurum at Forum on Microbial Threats workshop
Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought
Webinar: Invest to find TB to End TB
Prompt diagnosis and treatment of TB are essential to achieving the End TB strategy goal of a world free of TB by 2035.
The COVID-19 pandemic has had a
The Aurum Institute World TB Day Press Release
JOHANESBURG (24 MARCH 2022) Today, on World Tuberculosis Day, The Aurum Institute acknowledges the progress made and the challenges that lie ahead in efforts to end tuberculosis (TB). While COVID-19
